{"nct_id":"NCT02924402","title":"Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2016-10","start_date_type":"ACTUAL","primary_completion_date":"2024-04","primary_completion_date_type":"ACTUAL","completion_date":"2024-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["XNCR"]}